Growing incidence of heart attack due to stroke and other chronic cardiovascular
disorders is projected to result in significant growth of the pacemaker segment.
Moreover, introduction of technologically advanced products is anticipated to further
drive industry growth over the forecast period.
Browse key industry insights from the report “Cardiac Prosthetic Devices Market
Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy,
France, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia),
Application Development Potential, Price Trends, Competitive Market Share &
Forecast, 2017 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/cardiac-prosthetic-devices-market
Heart valve replacement devices are highly effective for cardiovascular diseases, due to
its benefits in patients suffering from extensive congenital malformation, calcification,
or infection. Transcatheter heart valve replacement will gain significant growth over
the forecast period owing to its less invasive nature compared to alternative surgical
procedures. The replacement device is considered as a highly potent alternative for
patients at greater risk from the standard valve replacement surgery.
Mechanical valves should foresee a substantial growth owing to the lifelong solution for
the patient due to the durable raw materials used in manufacturing. Moreover,
polymeric materials are widely used as raw materials, that minimize the clinical
problems associated with mechanical valves. There is lesser requirement for repetitive
surgeries with this type of valve.
U.S. cardiac prosthetic devices market led the regional segment due to increasing
awareness levels among the affected population. The American Heart Association is
focusing on cardiovascular disease prevention through promotion of positive health.
The prevalence of cardiovascular diseases is higher among the children and young
adults in U.S. owing to their unhealthy lifestyle. Asia Pacific will show significant growth
over the forecast timeframe. The growth is mainly attributed to increased prevalence of
target diseases in this region, which in turn is raising the mortality rate.
Some of the companies operating include Medtronic, Sorin Group, Boston Scientific,
Siemens Healthcare, Edwards Lifesciences, St. Jude Medical and Abbott Vascular. Most
of the companies are focusing on technological advancements and increasing safety of
the cardiac prosthetic devices, this will increase demand for such products. The
companies are also focusing on new product development, geographical expansion, and
mergers & acquisitions. For instance, in 2016, St. Jude Medical launched Trifecta Valve
with Glide Technology in the U.S. that utilize advanced technology, which is further
expected to foster the industry growth.
2 | Page